Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Biomed Pharmacother ; 103: 1498-1506, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29864935

RESUMEN

Stem barks of Drimys brasiliensis (Winteraceae) are consumed by the population in the form of a condiment. It is widely used to treat gastric and stomach problems and also to treat cancer. The extracts have demonstrated antiproliferative, antileishmanial and antimicrobial activities assigned to drimane sesquiterpenes. This study aimed to optimize the extraction conditions of the drimanes sesquiterpenes identified as 1-ß-(p-coumaroyloxy)-polygodial 1, drimanial 2 and 1-ß-(p-methoxycinnamoyl)-polygodial 3 in stem bark extracts. The HPLC-DAD method was developed and validated for the quantification of drimanes 1-3. The cytotoxic activity of these drimanes in human cancer cells, and the toxicological effects of the hydroethanolic extract, were determined. The extracts were prepared using different extractive conditions (solvents, plant: solvent ratio and time). The cytotoxicity effect was evaluated against leukemia, lymphomas, carcinomas and sarcomas cells using the tetrazolium assay (MTT). Furthermore, the acute toxicity was determined by measuring the biochemical parameters and by histopathological analysis. The hemolytic activity and micronucleus test were also performed. The method was linear, sensitive, precise and accurate for both drimanes 1-3. The best condition for extraction was using dichloromethane with plant: solvent proportion 1:10 (w/v) for six hours under dynamic maceration. Isolated drimanes exhibited cytotoxic effects with IC50 values ​​ranging from 0.13 to 112.67 µM. Compound 1 demonstrated significant results for acute promyelocytic leukemia (NB4) and Burkitt's lymphoma (RAMOS) cells while driamane 3 for Burkitt's lymphoma (RAJI) and acute T cell leukemia (MOLT4) cells. No signs of toxicity was observed and neither was mutagenicity or hemolytic activity.


Asunto(s)
Drimys/química , Corteza de la Planta/química , Tallos de la Planta/química , Sesquiterpenos/farmacología , Sesquiterpenos/toxicidad , Pruebas de Toxicidad Aguda , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Etanol/química , Hemólisis/efectos de los fármacos , Humanos , Límite de Detección , Pruebas de Micronúcleos , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Sesquiterpenos Policíclicos , Ratas Wistar , Reproducibilidad de los Resultados , Sesquiterpenos/química
2.
Biomed Res Int ; 2014: 636839, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25386561

RESUMEN

The aim of the study was to analyze the constituents of the dichloromethane fraction obtained from A. moluccana and also to evaluate the anti-inflammatory and antinociceptive properties of α,ß-amyrenone isolated from A. moluccana in mice. The dichloromethane fraction was evaluated by gas chromatography and submitted to purification. The mixture of α,ß-amyrenone was isolated and then evaluated using the carrageenan-induced paw-oedema or pleurisy and CFA-induced arthritis models in mice. Five triterpenes, α,ß-amyrenone, glutinol, and α,ß-amyrin were isolated from dichloromethane fraction of A. moluccana leaf extract. The mixture of α,ß-amyrenone, dosed orally, was able to reduce mechanical hypersensitivity and paw-oedema induced by carrageenan, interfering with neutrophil migration. Similar results were observed in the carrageenan-induced pleurisy model. Repeated administration of the compounds was also effective in reducing the mechanical sensitization and oedema developed in the arthritis model induced by CFA. In conclusion, the results demonstrate that α,ß-amyrenone interferes in both acute and chronic inflammatory processes. We can infer that these effects involve, at least in part, a reduction in the neutrophil migration. Therefore, it seems reasonable to suggest that α,ß-amyrenone could represent a new therapeutic tool for the management of painful and inflammatory diseases, especially those presenting a chronic profile.


Asunto(s)
Hipersensibilidad/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Triterpenos/administración & dosificación , Aleurites/química , Animales , Edema/tratamiento farmacológico , Edema/patología , Hipersensibilidad/patología , Inflamación/patología , Masculino , Ratones , Dolor/tratamiento farmacológico , Dolor/patología , Fitoterapia , Extractos Vegetales/química , Triterpenos/química
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda